IPHA•benzinga•
Innate Pharma Reports Q1 Revenue Of €1.2M, €72.5M Cash Position Excluding €15M Sanofi Investment; Highlights Progress Across ANKET® And ADC Programs With Runway To Mid-2026
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 13, 2025 by benzinga